Cite
HARVARD Citation
Chung, H. et al. (n.d.). P-094KEYNOTE-811 pembrolizumab plus trastuzumab and chemotherapy for HER2+ metastatic gastric or gastroesophageal junction cancer: a double-blind, randomized, placebo-controlled phase 3 study. Annals of oncology. p. . [Online].